GB2211737B - Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative - Google Patents
Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivativeInfo
- Publication number
- GB2211737B GB2211737B GB8829793A GB8829793A GB2211737B GB 2211737 B GB2211737 B GB 2211737B GB 8829793 A GB8829793 A GB 8829793A GB 8829793 A GB8829793 A GB 8829793A GB 2211737 B GB2211737 B GB 2211737B
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid derivative
- formulations containing
- aqueous formulations
- piperidinylcyclopentylheptenoic
- piperidinylcyclopentylheptenoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JAIYKLJZOBJGSG-UHFFFAOYSA-N 2-cyclopentyl-3-piperidin-1-ylhept-2-enoic acid Chemical class C1CCCC1C(C(O)=O)=C(CCCC)N1CCCCC1 JAIYKLJZOBJGSG-UHFFFAOYSA-N 0.000 title 1
- 239000013011 aqueous formulation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878729823A GB8729823D0 (en) | 1987-12-22 | 1987-12-22 | Complexes |
| GB888804422A GB8804422D0 (en) | 1988-02-25 | 1988-02-25 | Complexes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8829793D0 GB8829793D0 (en) | 1989-02-15 |
| GB2211737A GB2211737A (en) | 1989-07-12 |
| GB2211737B true GB2211737B (en) | 1991-12-11 |
Family
ID=26293226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8829793A Expired - Fee Related GB2211737B (en) | 1987-12-22 | 1988-12-21 | Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative |
Country Status (29)
| Country | Link |
|---|---|
| JP (1) | JPH02210A (fr) |
| KR (1) | KR890009402A (fr) |
| CN (1) | CN1034132A (fr) |
| AT (1) | AT395943B (fr) |
| AU (1) | AU615245B2 (fr) |
| BE (1) | BE1001704A3 (fr) |
| CA (1) | CA1328078C (fr) |
| CH (1) | CH676665A5 (fr) |
| DE (1) | DE3843059A1 (fr) |
| DK (1) | DK712888A (fr) |
| ES (1) | ES2011727A6 (fr) |
| FI (1) | FI885920A (fr) |
| FR (1) | FR2624731B1 (fr) |
| GB (1) | GB2211737B (fr) |
| GR (1) | GR880100854A (fr) |
| HU (1) | HU204700B (fr) |
| IE (1) | IE61995B1 (fr) |
| IL (1) | IL88764A0 (fr) |
| IT (1) | IT1224835B (fr) |
| LU (1) | LU87411A1 (fr) |
| MY (1) | MY103952A (fr) |
| NL (1) | NL8803126A (fr) |
| NO (1) | NO885689L (fr) |
| NZ (1) | NZ227446A (fr) |
| PH (1) | PH24982A (fr) |
| PL (1) | PL276595A1 (fr) |
| PT (1) | PT89301B (fr) |
| SE (1) | SE502288C2 (fr) |
| ZW (1) | ZW18088A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814725D0 (en) * | 1988-06-21 | 1988-07-27 | Glaxo Group Ltd | Medicaments |
| AU616571B2 (en) * | 1988-10-28 | 1991-10-31 | Shiseido Company Ltd. | Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin |
| IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| KR100825736B1 (ko) * | 2005-12-07 | 2008-04-29 | 한국전자통신연구원 | 무선 ｘｍｌ 전자 서명 서비스 제공 장치 및 그 방법 |
| KR100832740B1 (ko) * | 2007-01-17 | 2008-05-27 | 한국과학기술원 | 분지쇄 아미노산 생성능이 개선된 변이 미생물 및 이를이용한 분지쇄 아미노산의 제조방법 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2097397A (en) * | 1981-04-29 | 1982-11-03 | Glaxo Group Ltd | Aminocyclopentanol acids and esters as prostaglandin analogues and their preparation and pharmaceutical formulation |
| GB2127406A (en) * | 1982-09-16 | 1984-04-11 | Glaxo Group Ltd | Piperidinylcyclopentanolheptenoic acid salt |
| WO1985002767A1 (fr) * | 1983-12-21 | 1985-07-04 | Janssen Pharmaceutica N.V. | Compositions pharmaceutiques contenant des medicaments instables ou peu solubles dans l'eau et leurs procedes de preparation |
| JPS60150039A (ja) * | 1984-01-17 | 1985-08-07 | Minolta Camera Co Ltd | 水陸両用固定焦点カメラ |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503362B1 (fr) * | 1970-06-10 | 1975-02-04 | ||
| JPS5443569B2 (fr) * | 1972-07-05 | 1979-12-20 | ||
| HU181703B (en) * | 1980-05-09 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents |
| JPS58116423A (ja) * | 1981-12-28 | 1983-07-11 | Sumitomo Chem Co Ltd | メタノプロスタサイクリン製剤組成物 |
| JPS58192821A (ja) * | 1982-04-30 | 1983-11-10 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患の治療剤 |
| JPS5946228A (ja) * | 1982-09-08 | 1984-03-15 | Zeria Shinyaku Kogyo Kk | 生物学的に活性な有機化合物の水溶性及びリンパ移行性薬剤の製造方法 |
| JPS5973576A (ja) * | 1982-09-16 | 1984-04-25 | グラクソ・グル−プ・リミテツド | ピペリジニルシクロペンタノ−ルヘプテン酸塩 |
| DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
| JPS6327440A (ja) * | 1986-07-18 | 1988-02-05 | Sanraku Inc | グルコシル化分岐シクロデキストリン含有組成物 |
-
1988
- 1988-12-21 PT PT89301A patent/PT89301B/pt not_active IP Right Cessation
- 1988-12-21 CH CH4758/88A patent/CH676665A5/de not_active IP Right Cessation
- 1988-12-21 AU AU27356/88A patent/AU615245B2/en not_active Ceased
- 1988-12-21 AT AT0313088A patent/AT395943B/de not_active IP Right Cessation
- 1988-12-21 DK DK712888A patent/DK712888A/da not_active Application Discontinuation
- 1988-12-21 HU HU886537A patent/HU204700B/hu not_active IP Right Cessation
- 1988-12-21 FI FI885920A patent/FI885920A/fi not_active Application Discontinuation
- 1988-12-21 NO NO88885689A patent/NO885689L/no unknown
- 1988-12-21 NZ NZ227446A patent/NZ227446A/xx unknown
- 1988-12-21 IT IT8848702A patent/IT1224835B/it active
- 1988-12-21 JP JP63320759A patent/JPH02210A/ja active Pending
- 1988-12-21 IE IE382088A patent/IE61995B1/en not_active IP Right Cessation
- 1988-12-21 SE SE8804607A patent/SE502288C2/sv not_active IP Right Cessation
- 1988-12-21 ES ES8803876A patent/ES2011727A6/es not_active Expired - Fee Related
- 1988-12-21 GB GB8829793A patent/GB2211737B/en not_active Expired - Fee Related
- 1988-12-21 NL NL8803126A patent/NL8803126A/nl not_active Application Discontinuation
- 1988-12-21 BE BE8801423A patent/BE1001704A3/fr not_active IP Right Cessation
- 1988-12-21 CA CA000586606A patent/CA1328078C/fr not_active Expired - Fee Related
- 1988-12-21 FR FR8816902A patent/FR2624731B1/fr not_active Expired - Fee Related
- 1988-12-21 ZW ZW180/88A patent/ZW18088A1/xx unknown
- 1988-12-21 CN CN88108916A patent/CN1034132A/zh active Pending
- 1988-12-21 PH PH37963A patent/PH24982A/en unknown
- 1988-12-21 GR GR880100854A patent/GR880100854A/el unknown
- 1988-12-21 LU LU87411A patent/LU87411A1/fr unknown
- 1988-12-21 DE DE3843059A patent/DE3843059A1/de not_active Ceased
- 1988-12-21 PL PL27659588A patent/PL276595A1/xx unknown
- 1988-12-21 KR KR1019880017106A patent/KR890009402A/ko not_active Application Discontinuation
- 1988-12-22 IL IL88764A patent/IL88764A0/xx not_active IP Right Cessation
- 1988-12-22 MY MYPI88001508A patent/MY103952A/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2097397A (en) * | 1981-04-29 | 1982-11-03 | Glaxo Group Ltd | Aminocyclopentanol acids and esters as prostaglandin analogues and their preparation and pharmaceutical formulation |
| GB2127406A (en) * | 1982-09-16 | 1984-04-11 | Glaxo Group Ltd | Piperidinylcyclopentanolheptenoic acid salt |
| WO1985002767A1 (fr) * | 1983-12-21 | 1985-07-04 | Janssen Pharmaceutica N.V. | Compositions pharmaceutiques contenant des medicaments instables ou peu solubles dans l'eau et leurs procedes de preparation |
| JPS60150039A (ja) * | 1984-01-17 | 1985-08-07 | Minolta Camera Co Ltd | 水陸両用固定焦点カメラ |
Non-Patent Citations (2)
| Title |
|---|
| Chem. Pharm. Bull.,28(7), 1975-80 (1980) * |
| J. Pharm. Sci. 67(12), 1665-8 (1978) * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2207672B (en) | Sulphonamidothienylcarboxyic acid compounds | |
| EP0291245A3 (en) | Benzoylaminophenoxybutanoic acid derivatives | |
| JPS6413097A (en) | Phosphonic acid derivative | |
| IL92497A0 (en) | Beta-amino-boronic acid derivatives | |
| GB2203149B (en) | New ribofuranuronic acid derivatives | |
| EP0345359A4 (en) | Novel hydroxamic acid derivative | |
| GB8703749D0 (en) | Piperazinecarboxylic acid | |
| ZW9288A1 (en) | Hydocinnamic acid derivatives | |
| GB2211737B (en) | Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative | |
| GB2207428B (en) | Naphthalenepropionic acid derivatives | |
| GB8723895D0 (en) | Preparing-phenyl-propionic acid derivative | |
| EP0320000A3 (en) | Hydroxamic acid derivatives | |
| ZA889531B (en) | Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative | |
| IL80251A (en) | Herbicidal compositions comprising a phosphinylacetic acid derivative | |
| ZA884649B (en) | Preparation of a piperidinylcyclopentylheptenoic acid derivative | |
| ZA88145B (en) | 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives | |
| ZW13589A1 (en) | Panicillanic acid derivatives | |
| GB8809871D0 (en) | -amino-alkanoic acid derivative & processes | |
| JPS6413096A (en) | 1-aminoethylphosphinic acid derivative | |
| IE872256L (en) | Thiopenem-carboxylic acid derivative | |
| IE871285L (en) | 2-cyanonicotinic acid derivatives | |
| IE873378L (en) | Furanuronic acid derivatives | |
| JPS6413095A (en) | 1-aminoethylphosphinic acid | |
| ZA882384B (en) | New ribofuranuronic acid derivatives | |
| PH25870A (en) | 3-aminobenzoic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19961221 |